Race-based therapeutics.

@article{Bloche2004RacebasedT,
  title={Race-based therapeutics.},
  author={Maxwell Gregg Bloche},
  journal={The New England journal of medicine},
  year={2004},
  volume={351 20},
  pages={
          2035-7
        }
}
Are we moving into a new era of race-based therapeutics? Dr. M. Gregg Bloche asserts that greater awareness that race is at best a placeholder for other predispositions, and not a biologic verity, would be a first step. 
View PDF
37 Citations
7 Cite Background
1 Cite Methods

Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 37 CITATIONS

Cardiologists' Perspectives on Race-Based Drug Labels and Prescribing Within the Context of Treating Heart Failure

The Biological Basis of Performativity of Identity - Linking Scientific Evidence to Social Theory

VIEW 1 EXCERPT
CITES BACKGROUND

Race, Ethnicity and Ancestry in Unrelated Transplant Matching for the National Marrow Donor Program: A Comparison of Multiple Forms of Self-Identification with Genetics

The future of pharmacogenetics in the treatment of heart failure.

Personalized Medicine, Availability, and Group Disparity: An Inquiry into How Physicians Perceive and Rate the Elements and Barriers of Personalized Medicine

HUMANS, ANIMALS, AND PETRI DISHES: BIOMEDICAL MODELING BETWEEN EXPERIMENTATION AND REPRESENTATION

VIEW 2 EXCERPTS
CITES BACKGROUND

Variation in corneal hysteresis and central corneal thickness among black, hispanic and white subjects.

VIEW 1 EXCERPT
CITES METHODS

Addressing the “Research Gap” in Special Education Through Mixed Methods

VIEW 1 EXCERPT
CITES BACKGROUND

Deliberating about race as a variable in biomedical research.

  • Anton A van Niekerk
  • Medicine
  • South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
  • 2011

Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF).

References

Publications referenced by this paper.
SHOWING 1-4 OF 4 REFERENCES

How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.

  • Jonathan Kahn
  • Medicine
  • Yale journal of health policy, law, and ethics
  • 2004

Social Isolation and Health, with an Emphasis on Underlying Mechanisms

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure

  • JN Cohn, DG Archibald, S Ziesche
  • N Engl J Med
  • 1991